INBS 10-K: Going Concern Warning, $12.4M Loss, but Revenue Up 38%

summarizeSummary

Intelligent Bio Solutions filed its annual report with a going concern warning, a wider net loss of $12.4 million, but strong revenue growth of 38% and remediation of internal control weaknesses.

check_boxKey Events · Earnings and Guidance · INBS

• Going Concern Warning

  Cash of $3.99 million as of June 30, 2026, is insufficient to fund operations for the next 12 months, raising substantial doubt about the company's ability to continue as a going concern.

• Net Loss Widens

  Net loss attributable to INBS increased to $12.43 million from $10.57 million, driven by higher selling, general, and administrative expenses and development costs.

• Revenue Growth

  Revenue grew 38.1% to $4.22 million, with cartridge sales up 41.1%, and gross margin improved to 48.6% from 40.9%.

• Internal Controls Remediated

  Management concluded that previously reported material weaknesses in internal control over financial reporting were remediated as of June 30, 2026.

auto_awesomeAnalysis · INBS · Industrial Applications And Services

The annual report confirms the company's cash of $3.99 million is insufficient to fund operations for the next 12 months, raising substantial doubt about its ability to continue as a going concern. Net loss widened to $12.43 million from $10.57 million, driven by higher selling and regulatory expenses. Revenue grew 38.1% to $4.22 million, and gross margin improved to 48.6%. Management remediated previously reported material weaknesses in internal controls. The company has 6.1 million warrants outstanding and continues to raise capital through an ATM facility, with $4.29 million raised through August 18, 2026.